JP2008546716A5 - - Google Patents

Download PDF

Info

Publication number
JP2008546716A5
JP2008546716A5 JP2008517215A JP2008517215A JP2008546716A5 JP 2008546716 A5 JP2008546716 A5 JP 2008546716A5 JP 2008517215 A JP2008517215 A JP 2008517215A JP 2008517215 A JP2008517215 A JP 2008517215A JP 2008546716 A5 JP2008546716 A5 JP 2008546716A5
Authority
JP
Japan
Prior art keywords
seq
antibody
antigen
amino acid
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008517215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008546716A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/023821 external-priority patent/WO2006138721A1/en
Publication of JP2008546716A publication Critical patent/JP2008546716A/ja
Publication of JP2008546716A5 publication Critical patent/JP2008546716A5/ja
Withdrawn legal-status Critical Current

Links

JP2008517215A 2005-06-17 2006-06-16 抗ＧＦＲα３抗体 Withdrawn JP2008546716A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69185005P 2005-06-17 2005-06-17
PCT/US2006/023821 WO2006138721A1 (en) 2005-06-17 2006-06-16 Anti-gfralpha3 antibodies

Publications (2)

Publication Number Publication Date
JP2008546716A JP2008546716A (ja) 2008-12-25
JP2008546716A5 true JP2008546716A5 (cg-RX-API-DMAC7.html) 2009-07-30

Family

ID=37570787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008517215A Withdrawn JP2008546716A (ja) 2005-06-17 2006-06-16 抗ＧＦＲα３抗体

Country Status (5)

Country Link
US (1) US20090202562A1 (cg-RX-API-DMAC7.html)
EP (1) EP1896047A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008546716A (cg-RX-API-DMAC7.html)
CA (1) CA2612417A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006138721A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3462B1 (ar) * 2012-08-22 2020-07-05 Regeneron Pharma أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها
US11542332B2 (en) 2016-03-26 2023-01-03 Bioatla, Inc. Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof
MX2021012335A (es) * 2019-04-10 2021-11-12 Regeneron Pharma Anticuerpos humanos que se unen a ret y metodos de uso de los mismos.
EP4406972A4 (en) * 2021-09-24 2025-12-31 Daegu Gyeongbuk Inst Science & Tech GFRAL ANTAGONIST ANTIBODY WITH IMPROVED AFINITY, AND ITS USE
KR102864956B1 (ko) * 2021-09-24 2025-09-30 재단법인대구경북과학기술원 친화도가 개선된 gfral 길항 항체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6677135B1 (en) * 1996-05-08 2004-01-13 Biogen, Inc. Ret ligand (RetL) for stimulating neutral and renal growth
EP0962467A4 (en) * 1996-09-26 2002-10-30 Chugai Pharmaceutical Co Ltd Antibody against human parathormone related peptides
EP1156062A1 (en) * 2000-05-12 2001-11-21 GPC Biotech AG Immunomodulatory human MHC class II antigen-binding peptides/proteins

Similar Documents

Publication Publication Date Title
US20230287119A1 (en) Anti-cd3 antibody and molecules comprising the antibody
HRP20191462T1 (hr) Antitijela usmjerena protiv her-3 i njihove uporabe
JP2015535828A5 (cg-RX-API-DMAC7.html)
JP2017048240A5 (cg-RX-API-DMAC7.html)
RU2017114341A (ru) Антитела к pd-l1, связывающие pd-l1 собаки
JP2021508469A5 (cg-RX-API-DMAC7.html)
HRP20201375T1 (hr) ANTI-BCMA ANTITIJELA, BISPECIFIČNI ANTIGEN VEŽUĆE MOLEKULE KOJE SE VEŽU ZA BCMA i CD3, I NJIHOVE UPOTREBE
JP2017505125A5 (cg-RX-API-DMAC7.html)
NO20066052L (no) Anti-CD3 antistoffer og fremgangsmater for anvendelse derav
JP2021525546A5 (cg-RX-API-DMAC7.html)
JP2009225799A5 (cg-RX-API-DMAC7.html)
CA2818635C (en) Antibodies selective for cells presenting erbb2 at high density
JP2018520657A5 (cg-RX-API-DMAC7.html)
IL273196B2 (en) Claudin6 antibodies and methods of treating cancer
JP2013198490A5 (cg-RX-API-DMAC7.html)
JP2013506428A5 (cg-RX-API-DMAC7.html)
JP2019535254A5 (ja) 抗ｐｄ−ｌ１抗体および変異型
FI3322727T3 (fi) Humanisoituja tai kimeerisiä CD3-vasta-aineita
JP2018503380A5 (cg-RX-API-DMAC7.html)
JP2012525829A5 (cg-RX-API-DMAC7.html)
JP2010535205A5 (cg-RX-API-DMAC7.html)
RU2015126533A (ru) Анти-cd47 антитела и способы их применения
JP2011517447A5 (cg-RX-API-DMAC7.html)
JP2014526898A5 (cg-RX-API-DMAC7.html)
RU2010129045A (ru) Связывающие молекулы к рецептору ох40 человека